Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia [PDF]
Jiaming Li +8 more
openalex +1 more source
Long‐term remission of type B insulin resistance syndrome with immunotherapy: A case report
ABSTRACT We report long‐term remission in a patient with type B insulin resistance achieved with a combination of immunotherapies. A 55‐year‐old Japanese man presented with nocturnal hypoglycemia and cytopenia. He also had postprandial hyperglycemia due to severe insulin resistance, which was difficult to manage using high‐dose insulin and recombinant ...
Erika Egawa +3 more
wiley +1 more source
Relapsing Chronic Immune Thrombocytopenia and Thrombosis: A Case Report. [PDF]
Kose L.
europepmc +1 more source
Platelet Levels Associated With Bleeding Risk for Dental Interventions: A Systematic Review
ABSTRACT Objectives To evaluate evidence in relation to postoperative bleeding in humans aged ≥ 16 with preoperative platelet counts < 50,000/μL, compared to those above, undergoing dental interventions. Methods Quantitative synthesis without meta‐analysis was conducted through an electronic search conducted on Ovid MEDLINE and Embase from 1946 to ...
Guang Xu David Lim +3 more
wiley +1 more source
Combination of anti-CD20 and hetrombopag in relapsed/refractory immune thrombocytopenia: a case series. [PDF]
Zhang X +6 more
europepmc +1 more source
Malaria polymerase chain reaction (PCR) testing is more sensitive than conventional diagnostics. Routine PCR screening of at‐risk asymptomatic hematopoietic cell donors and transplant candidates may prevent unnecessary deferrals or treatment. In our experience, PCR negativity during screening or after treatment supports donor/candidate eligibility ...
Mary M. Czech +5 more
wiley +1 more source
Mesenchymal stem cells therapy for immune thrombocytopenia in pregnancy: a case report. [PDF]
Tong T +7 more
europepmc +1 more source
HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni +9 more
wiley +1 more source
Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes. [PDF]
Ali SA +9 more
europepmc +1 more source

